Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07501507

Methotrexate Treatment in Hand Osteoarthritis Refractory to Usual Treatments

Methotrexate Treatment in Hand Osteoarthritis Refractory to Usual Treatments: A Randomised, Double-blind, Placebo-controlled Trial

Status
Not Yet Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
170 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Randomized study comparing the structural efficacy of methotrexate versus placebo in digital osteoarthritis

Conditions

Interventions

TypeNameDescription
DRUGMethotrexate Injectable SolutionInjection of methotrexate every week during 12 month
DRUGPlaceboThe placebo consists of a 0.9% solution of sodium chloride (NaCl) in sterile distilled water for injection. This solution was chosen as the placebo. Injection every week during 12 month.

Timeline

Start date
2026-05-02
Primary completion
2027-10-01
Completion
2027-10-01
First posted
2026-03-30
Last updated
2026-03-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07501507. Inclusion in this directory is not an endorsement.